CoChat

Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer

Open access
Mohammed, Azharuddin, Arastu, Zubair · 2017 · BMC Urology

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Intravesical Bacilli Calmette-Guerin (IVBCG) therapy for non-muscle invasive bladder cancer (NMIBC) has long been in use successfully. Albeit rarely, we still face with its safety concerns more than 25 years on since its approval by US Food and Drug Agency in 1990. Local and systemic infection following intravesical BCG is widely reported as compared to immune mediated local or systemic hypersensitivity reactions involving kidneys; acute kidney injury (AKI) and other renal manifestations are well reported but not of chronic kidney disease (CKD). CASE: following IVBCG for NMIBC. Our patient's renal function plateaued when IVBCG was held; and worsened again when reinstilled. It introduces the concept of 'repetitive' immune mediated renal injury presenting as progressive CKD rather than AKI, as is generally reported. Although response was poor, corticosteroids stopped CKD progression to end stage renal disease. CONCLUSIONS: We highlight the need for increased awareness and early recognition of IVBCG renal complications by both urologists and nephrologists in order to prevent progressive and irreversible renal damage. Low incidence of IVBCG renal complications may also be due to under recognition in the era prior to CKD Staging and AKI Network (and AKI e-alerts) that defined AKI as a rise in serum creatinine of ≥26umol/L; hence an unmet need for urgent prospective studies. Major literature review focuses on emerging spectrum of histopathological IVBCG related renal complications and their outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12894-017-0304-5

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Graph illustrating effect of intravesical BCG on renal function during treatment and following discontinuation
Fig. 1 Graph illustrating effect of intravesical BCG on renal function during treatment and following discontinuationCC BY · PubMed Central
Fig. 2 Renal outcome in Intravesical BCG related granulomatous and non-granulomatous renal disease
Fig. 2 Renal outcome in Intravesical BCG related granulomatous and non-granulomatous renal diseaseCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 21

Metadata

Authors
Mohammed, A., & Arastu, Z.
Affiliations
Royal Shrewsbury Hospital (GB)
Corresponding author
Mohammed, Azharuddin
Venue
BMC Urology
Published
2017-12
Volume
17
Issue
1
Pages
114-114
ISSN
1471-2490 (ISSN-L)
OpenAlex
W2772750305
Cited by
20
References
26
Citations by year
2026: 4 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 1
FWCI
1.96
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Urology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
Keywords
BCG immunotherapy, non-muscle-invasive bladder cancer, kidney injury, chronic kidney disease, acute kidney injury, hypersensitivity, corticosteroid therapy, end-stage renal disease, histopathology
MeSH terms
Administration, Intravesical, Aged, BCG Vaccine, Urinary Bladder Neoplasms, Female, Humans, Neoplasm Invasiveness, Acute Kidney Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer. https://app.cochat.ai/papers/10.1186/s12894-017-0304-5
The paper
Mohammed, A., & Arastu, Z. (2017). Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer. BMC Urology. https://doi.org/10.1186/s12894-017-0304-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.